U.S. Markets closed
  • S&P 500

    4,395.64
    +41.45 (+0.95%)
     
  • Dow 30

    34,258.32
    +338.48 (+1.00%)
     
  • Nasdaq

    14,896.85
    +150.45 (+1.02%)
     
  • Russell 2000

    2,218.56
    +32.38 (+1.48%)
     
  • Gold

    1,768.40
    -9.80 (-0.55%)
     
  • Silver

    23.03
    +0.46 (+2.05%)
     
  • EUR/USD

    1.1696
    -0.0034 (-0.2924%)
     
  • 10-Yr Bond

    1.3360
    +0.0120 (+0.91%)
     
  • Vix

    20.87
    -3.49 (-14.33%)
     
  • GBP/USD

    1.3619
    -0.0045 (-0.3282%)
     
  • USD/JPY

    109.7800
    +0.5600 (+0.5127%)
     
  • BTC-USD

    42,509.44
    -1,924.11 (-4.33%)
     
  • CMC Crypto 200

    1,089.55
    +49.07 (+4.72%)
     
  • FTSE 100

    7,083.37
    +102.39 (+1.47%)
     
  • Nikkei 225

    29,639.40
    -200.31 (-0.67%)
     

Company News for Jun 29, 2021

·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Shares of Intellia Therapeutics, Inc. NTLA surged 50.2% after the company reported positive clinical data for its CRISPR therapy.

  • Anavex Life Sciences Corp.’s AVXL shares jumped 16.6% after the company reported that its ANAVEX2-73 has improved MDS-UPDRS efficacy endpoints with significant biomarker correlation in placebo-controlled Phase 2 clinical trial for treatment of Parkinson's.

  • Shares of MannKind Corporation MNKD rose 11.6% after the company reported that Medicare patients will be able to use its Afrezza and continuous glucose monitoring devices starting in July.

  • Kymera Therapeutics, Inc.’s KYMR shares jumped 6.3% after the company reported that its KT-474 has achieved and exceeded Phase 1 target degradation of 85% within the SAD portion of the Phase 1 trial.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
MannKind Corporation (MNKD) : Free Stock Analysis Report
 
Anavex Life Sciences Corp. (AVXL) : Free Stock Analysis Report
 
Intellia Therapeutics, Inc. (NTLA) : Free Stock Analysis Report
 
Kymera Therapeutics, Inc. (KYMR) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research